Repatha (evolocumab) is an injectable medicine that helps lower levels of low-density lipoprotein cholesterol (LDL), often called “bad” cholesterol. Approved in 2015, Repatha can now be used in adults ...
The FDA has expanded approval of Amgen’s PCSK9 inhibitor Repatha (evolocumab), permitting use in adults at increased risk of major adverse cardiovascular events due to uncontrolled LDL cholesterol, ...
(RTTNews) - Amgen (AMGN) announced the FDA has broadened the approved use of Repatha or evolocumab to include adults at increased risk for major adverse cardiovascular events due to uncontrolled ...
Hosted on MSN
Amgen says FDA broadens the approved use of Repatha
Amgen (AMGN) announced that the U.S. FDA has broadened the approved use of Repatha to include adults at increased risk for major adverse cardiovascular events due to uncontrolled low-density ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback